[en] Parkinson's disease (PD) is the fastest growing neurological disorder worldwide, taking into account age-standardized rates for prevalence, disability and deaths (1). PD is characterized by a clinical symptomatology involving both motor and non-motor symptoms. According to the Global Burden of Disease study (2018), the global burden of this disorder has more than doubled over the past two decades from 2.5 million patients in 1990 to 6.1 million patients in 2016 (2).
In this editorial and eBook, we highlight the research done on PD by members of a global consortium known as the Genetic Epidemiology of Parkinson's disease (GEoPD) Consortium. We begin the editorial by providing a brief history of how GEoPD was started and how it has subsequently developed into an international endeavor. We then briefly summarize the completed and ongoing projects, and conclude with the future vision of this unique consortium.
Disciplines :
Génétique & processus génétiques
Auteur, co-auteur :
Farrer, Matthew J.; University of Florida > Department of Neurology
Bardien, Soraya; Faculty of Medicine and Health Sciences, Stellenbosch University, > Division of Molecular Biology and Human Genetics,
Hattori, Nobutaka
Lesage, Suzanne
Ross, Owen A.
Mellick, George D.; Griffith University > Griffith Institute for Drug Discovery
KRÜGER, Rejko ; University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB) > Translational Neuroscience
Co-auteurs externes :
yes
Langue du document :
Anglais
Titre :
Editorial: Celebrating the Diversity of Genetic Research to Dissect the Pathogenesis of Parkinson's Disease
